Skip to main content



COVID-19 and the Ethics of Democratizing Voice Computing

By Ankita Moss
NeuroLex is a company with the mission of using voice analysis techniques to detect health conditions early to reduce healthcare costs and improve patient outcomes. The company has created a product called SurveyLex, the “first voice-enabled survey platform,” that can collect voice samples across a wide range of digital devices. In a recent interview hosted by Microsoft for Startups, former NeuroLex CEO and current Vice President of Data and Research at Sonde Health, Jim Schwoebel, discusses the founding history of NeuroLex and its growth and utility during the COVID-19 pandemic. Mr. Schwoebel also answered questions for The Neuroethics Blog Team, addressing how and why neural data is useful, how voice data fits under the umbrella of neural data, how voice data relates to COVID-19, and how he manages ethical decision-making in this work. It is important to note that this interview was prior to the acquisition of SurveyLex by Sonde Health.Neural Data and BiomarkersThe con…

Latest Posts

The Social Impact of Brain Machine Interfaces: Closing Remarks

The Social Impact of Brain Machine Interfaces: Value Sensitive Design in Neurotechnology

The Benefits and Perils of COVID-19 Neuropsychiatric Studies

Facing Bias and Ethical Challenges in Facial Recognition Technology

The Social Impact of Brain Machine Interfaces: Structural Inequality in BMI Study and Practice

Follow Us

Follow Us
Emory Neuroethics on Facebook

Emory Neuroethics on Twitter

AJOB Neuroscience on Facebook